Development, preclinical and preanalytical evaluation of a rapid point-of-care naat device to determine ciprofloxacin sensitivity of gonococci in urogenital samples
Ended Project Grant Awarded Last action
- Award ID
- R44AI143012
- Recipient
-
Visby Medical, Inc. UEI LWNQZECSVHY1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- San Jose, CA 95134, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $300,000 |
Quick answers
Who received award R44AI143012?
R44AI143012 was awarded to Visby Medical, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 22, 2019.
How much is award R44AI143012 worth?
$300,000 has been obligated on R44AI143012.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award